Skip to main content

Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation.

Clinical case reports

Authors: Leona Dold, Philipp Lutz, Annkristin Heine, Tobias J Weismüller, Christian P Strassburg, Ulrich Spengler

Although ruxolitinib contributes to immunomodulation and can lead to severe infections, it seems a feasible treatment strategy for patients with polycythemia vera and myelofibrosis after liver transplantation.

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

PMID: 34504700

Participating cluster members